Overview

Lesogaberan in Chinese Patients With Refractory Reflux Symptoms

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Lesogaberan may be used in Chinese GERD patients with partial response to PPI.
Phase:
Phase 2
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Ministry of Science and Technology, Taiwan
Treatments:
Lesogaberan